Pubblicazioni

Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in primary antiphospholipid syndrome. the multicenter ATHERO-APS study

2022 - JOURNAL OF AUTOIMMUNITY

Bucci, T.; Ames, P. R.; Cammisotto, V.; Bartimoccia, S.; Triggiani, M.; Parente, R.; Ciampa, A.; Pignatelli, P.; Carnevale, R.; Pastori, D.

Is it Time for Single-Pill Combinations in Dyslipidemia?

2022 - AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS

Schiele, FranÃ§ois; PÃ©rez de Isla, Leopoldo; Arca, Marcello; Vlachopoulos, Charalambos

Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol

2020 - NEW ENGLAND JOURNAL OF MEDICINE

K. K., Ray; R. S., Wright; D., Kallend; W., Koenig; L. A., Leiter; F. J., Raal; J. A., Bisch; T., Richardson; M., Jaros; P. L. J., Wijngaard; J. J. P., Kastelein; Sulli, N.

Evolocumab in pediatric heterozygous familial hypercholesterolemia

2020 - NEW ENGLAND JOURNAL OF MEDICINE

Santos, R. D.; Ruzza, A.; Hovingh, G. K.; Wiegman, A.; Mach, F.; Kurtz, C. E.; Hamer, A.; Bridges, I.; Bartuli, A.; Bergeron, J.; Szamosi, T.; Santra, S.; Stefanutti, C.; Descamps, O. S.; Greber-Platzer, S.; Luirink, I.; Kastelein, J. J. P.; Gaudet, D.

Evolocumab in pediatric heterozygous familial hypercholesterolemia

2020 - NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of PCSK9 monoclonal antibodies

2019 - EXPERT OPINION ON DRUG SAFETY

Iqbal, Z.; Dhage, S.; Mohamad, J. B.; Abdel-Razik, A.; Donn, R.; Malik, R.; Ho, J. H.; Liu, Y.; Adam, S.; Isa, B.; Stefanutti, C.; Soran, H.

Low density lipoprotein (LDL) cholesterol as a causal role for atherosclerotic disease. potential role of PCSK9 inhibitors

2019 - HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION

Del Pinto, R.; Grassi, D.; Properzi, G.; Desideri, G.; Ferri, C.

Relationship of PCSK9 and urinary thromboxane excretion to cardiovascular events in patients with atrial fibrillation

2017 - JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pastori, Daniele; Nocella, Cristina; Farcomeni, Alessio; Bartimoccia, Simona; Santulli, Maria; Vasaturo, Fortunata; Carnevale, Roberto; Menichelli, Danilo; Violi, Francesco; Pignatelli, Pasquale; Saliola, Mirella; Casciaro, Marco Antonio; Ferro, Domenico; Vicario, Tommasa; Albanese, Fabiana; Cribari, Francesco; Paladino, Alberto; Del Sole, Francesco; Novo, Marta; Cammisotto, Vittoria; Andreozzi, Paola; Di Stefano, Tiziana; Iannucci, Patrizia; Sabbatini, Elio

The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia. A network meta-analysis

2016 - EUROPEAN HEART JOURNAL

Lipinski, Michael J.; Benedetto, Umberto; Escarcega, Ricardo O.; Biondi-Zoccai, Giuseppe; Lhermusier, Thibault; Baker, Nevin C.; Torguson, Rebecca; Brewer, H. Bryan; Waksman, Ron

Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin typeÂ 9

2015 - CLINICAL SCIENCE

Page, Michael M; Stefanutti, Claudia; Sniderman, Allan; Watts, Gerald F.